Literature DB >> 11162650

Identification of a novel autoantigen UACA in patients with panuveitis.

K Yamada1, S Senju, T Nakatsura, Y Murata, M Ishihara, S Nakamura, S Ohno, A Negi, Y Nishimura.   

Abstract

To identify the target autoantigens in Vogt-Koyanagi-Harada disease, we made use of an immunoscreening of a bovine uveal cDNA expression library with serum samples obtained from patients with Vogt-Koyanagi-Harada disease. We identified a novel bovine antigen and homologous human autoantigen and designated it as UACA (uveal autoantigen with coiled coil domains and ankyrin repeats). mRNA of human UACA is expressed most abundantly in skeletal muscles and in various human tissues, including choroid, retina, and epidermal melanocytes. IgG autoantibodies were quantitated in an ELISA, using recombinant C-terminal 18.0% fragment of human UACA. The prevalence of IgG anti-UACA autoantibodies in patients with panuveitis (Vogt-Koyanagi-Harada disease, Behçet's disease, sarcoidosis) was significantly higher than that in healthy controls (19.6-28.1% vs 0%, P < 0.05) indicating that autoimmunity directed against UACA is a common phenomenon in these diseases. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162650     DOI: 10.1006/bbrc.2001.4189

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Paracrine apoptotic effect of p53 mediated by tumor suppressor Par-4.

Authors:  Ravshan Burikhanov; Tripti Shrestha-Bhattarai; Nikhil Hebbar; Shirley Qiu; Yanming Zhao; Gerard P Zambetti; Vivek M Rangnekar
Journal:  Cell Rep       Date:  2014-01-09       Impact factor: 9.423

2.  Novel mechanism of apoptosis resistance in cancer mediated by extracellular PAR-4.

Authors:  Ravshan Burikhanov; Tripti Shrestha-Bhattarai; Shirley Qiu; Nidhi Shukla; Nikhil Hebbar; Subodh M Lele; Craig Horbinski; Vivek M Rangnekar
Journal:  Cancer Res       Date:  2012-11-30       Impact factor: 12.701

3.  Frequent immune response to a melanocyte specific protein KU-MEL-1 in patients with Vogt-Koyanagi-Harada disease.

Authors:  S Otani; T Sakurai; K Yamamoto; T Fujita; Y Matsuzaki; Y Goto; Y Ando; S Suzuki; M Usui; M Takeuchi; Y Kawakami
Journal:  Br J Ophthalmol       Date:  2006-02-15       Impact factor: 4.638

Review 4.  [Molecular markers of various stages of nonsmall cell lung cancer development].

Authors:  I B Zborovskaia; A G Tatosian
Journal:  Mol Biol (Mosk)       Date:  2004 Mar-Apr

5.  RELATIONSHIP BETWEEN UVEITIS, DIFFERENT TYPES OF VIRAL HEPATITIS, AND LIVER CIRRHOSIS: A 12-Year Nationwide Population-Based Cohort Study.

Authors:  Peng-Tai Tien; Chun-Ju Lin; Yi-Yu Tsai; Huan-Sheng Chen; De-Kuang Hwang; Chih-Hsin Muo; Jane-Ming Lin; Wen-Lu Chen
Journal:  Retina       Date:  2016-12       Impact factor: 4.256

6.  Transcriptome and proteome analysis of the antitumor activity of maslinic acid against pancreatic cancer cells.

Authors:  Hewei Zhang; Lijun Kong; Yan Zhang; Cheng Wang; Linxiao Sun
Journal:  Aging (Albany NY)       Date:  2021-10-12       Impact factor: 5.682

7.  Ocular Manifestations Related to Antibodies Positivity and Inflammatory Biomarkers in a Rheumatological Cohort.

Authors:  Carlos Cifuentes-González; Pilar Uribe-Reina; Juliana Reyes-Guanes; Juliana Muñoz-Ortiz; Paula Tatiana Muñoz-Vargas; William Rojas-Carabali; Dora Victoria Nova-Florián; Ana Sofía De-Los-Ríos; Rubén Dario Mantilla-Hernández; Alejandra de-la-Torre
Journal:  Clin Ophthalmol       Date:  2022-08-09

8.  Proliferative vitreoretinopathy may be a risk factor in combined macular hole retinal detachment cases.

Authors:  Matthew A Cunningham; Ryan M Tarantola; James C Folk; Elliott H Sohn; H Culver Boldt; Jordan A Graff; Korianne Elkins; Stephen R Russell; Vinit B Mahajan
Journal:  Retina       Date:  2013-03       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.